As of Sep 30
| +2.45 / +21.19%|
The 8 analysts offering 12-month price forecasts for PTC Therapeutics Inc have a median target of 9.00, with a high estimate of 20.00 and a low estimate of 5.00. The median estimate represents a -35.76% decrease from the last price of 14.01.
The current consensus among 9 polled investment analysts is to Hold stock in PTC Therapeutics Inc. This rating has held steady since September, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.